Literature DB >> 11514383

Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway.

J L Rouleau1, G Kapuku, S Pelletier, H Gosselin, A Adam, C Gagnon, C Lambert, S Meloche.   

Abstract

BACKGROUND: The role of kinins in the cardioprotective effects of ACE inhibitors remains controversial. METHODS AND
RESULTS: Right ventricular pressure overload in rabbits was produced by pulmonary artery banding for 21 days. Rabbits were untreated, or they received the ACE inhibitor ramipril with or without bradykinin B(1) and B(2) receptor blockers or the angiotensin (Ang) II type I (AT(1)) receptor blocker losartan. Pulmonary artery banding caused right ventricular hypertrophy, depressed papillary muscle contractility, and loss of Ang II contractile effects because of a signaling defect downstream of AT(1) receptors. Paradoxically, AT(1) receptor density and G protein alpha subunits alphaq and alphai1/2 increased. Inotropic responsiveness to the alpha-receptor agonist phenylephrine was normal. Ramipril preserved cardiac contractility, but this effect was attenuated by simultaneous use of kinin receptor blockers. Ramipril also maintained responsiveness to Ang II and prevented AT(1) receptor and G protein upregulation. The simultaneous use of a kinin receptor blocker attenuated but did not prevent upregulation in the AT(1) receptor and G protein. Losartan had no effect on baseline contractility, but it maintained cardiac inotropic responsiveness to Ang II, prevented upregulation of AT(1) receptors, but did not modify G protein upregulation.
CONCLUSIONS: Pressure overload of the right ventricle decreases contractility, uncouples AT(1) receptors to downstream signaling pathways, and changes the expression of components of the AT(1) receptor signaling pathway. Ramipril attenuates these effects via kinins. Interventions that prevent local increases in Ang II or block AT(1) receptors also prevent decreased responsiveness of the AT(1) receptor in this model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514383     DOI: 10.1161/hc3401.093149

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.

Authors:  Roy Emanuel; Astha Chichra; Nirav Patel; Thierry H Le Jemtel; Abhishek Jaiswal
Journal:  Ann Transl Med       Date:  2018-08

Review 2.  Right side of heart failure.

Authors:  Maya Guglin; Sameer Verma
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 3.  Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.

Authors:  Pietro Ameri; Edoardo Bertero; Giovanni Meliota; Martino Cheli; Marco Canepa; Claudio Brunelli; Manrico Balbi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 4.  Emerging therapies for right ventricular dysfunction and failure.

Authors:  Anna Klinke; Torben Schubert; Marion Müller; Ekaterina Legchenko; Jason G E Zelt; Tsukasa Shimauchi; L Christian Napp; Alexander M K Rothman; Sébastien Bonnet; Duncan J Stewart; Georg Hansmann; Volker Rudolph
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

Review 5.  Novel therapeutic approaches to preserve the right ventricle.

Authors:  Samar Farha; Erika L Lundgrin; Serpil C Erzurum
Journal:  Curr Heart Fail Rep       Date:  2013-03

6.  Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent.

Authors:  Stefan Schäfer; Hans-Ludwig Schmidts; Markus Bleich; Andreas E Busch; Wolfgang Linz
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

7.  Pulmonary artery banding alters the expression of Ca2+ transport proteins in the right atrium in rabbits.

Authors:  Subash C Gupta; Kenneth D Varian; Naresh C Bal; Jessica L Abraham; Muthu Periasamy; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-17       Impact factor: 4.733

8.  Development of left ventricular diastolic dysfunction with preservation of ejection fraction during progression of infant right ventricular hypertrophy.

Authors:  Kazuo Kitahori; Huamei He; Mitsuhiro Kawata; Douglas B Cowan; Ingeborg Friehs; Pedro J Del Nido; Francis X McGowan
Journal:  Circ Heart Fail       Date:  2009-09-24       Impact factor: 8.790

9.  Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.

Authors:  Frances S de Man; Ly Tu; M Louis Handoko; Silvia Rain; Gerrina Ruiter; Charlène François; Ingrid Schalij; Peter Dorfmüller; Gérald Simonneau; Elie Fadel; Frederic Perros; Anco Boonstra; Piet E Postmus; Jolanda van der Velden; Anton Vonk-Noordegraaf; Marc Humbert; Saadia Eddahibi; Christophe Guignabert
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

10.  The right ventricle: biologic insights and response to disease.

Authors:  Lori A Walker; Peter M Buttrick
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.